Court Needs to Reread Expert Opinions Before Rendering Damages

Business Valuation UpdateVol. 15 No. 12
Legal and Court Case Update
December 2009
3841 Surgical and Medical Instruments and Apparatus
339112 Surgical and Medical Instrument Manufacturing
intellectual property

Spectralytics, Inc. v. Cordis Corp. (I)
2009 WL 2837358 (D. Minn.)
September 4, 2009
US
Federal Court
Minnesota
United States District Court
Michael J Timmons
Julie Davis (plaintiff)
Schlitz

Summary

Court upholds $22.5 million patent infringement damages based on 5% reasonable royalty rate, despite defendant’s arguments regarding lack of reliable comparables and evidence that the company sold for only $4 million.

See Also

Spectralytics, Inc. v. Cordis Corp. (I)

Court upholds $22.5 million patent infringement damages based on 5% reasonable royalty rate, despite defendant’s arguments regarding lack of reliable comparables and evidence that the company sold for only $4 million.